drugset / Trial / NCT01020526
Pregabalin In Adolescent Patients With Fibromyalgia
Non-randomizedOpen-labelTreatment
Summary
The main purpose of this study is to evaluate the long-term safety of pregabalin in adolescent patients who participated in the previous fibromyalgia study (A0081180) and who wish to recieve open-label pregabalin
Timeline
- Start
- 2010-09
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 75 mg | Oral |
| Subject | Pregabalin | Small molecule | 450 mg | Oral |